Osimertinib Targeted Lung Cancer Drug, Third Generation EGFR-TKI, irreversible, treats NSCLC with EGFR Ex19Del or EGFR L858R mutations, effective against central nervous system metastases,
Sale!
Lucius
Replica Osimertinib EGFR-TKI for NSCLC Treatment
Original price was: $647.00.$488.00Current price is: $488.00.
Osimertinib Targeted Lung Cancer Drug, Third Generation EGFR-TKI, irreversible, treats NSCLC with EGFR Ex19Del or EGFR L858R mutations, effective against central nervous system metastases,